Good manufacturing practices inspection policy for drug establishments : POL-0011.: H139-39/2022E-PDF
"Establishments need a drug establishment license (DEL) to be authorized to conduct the following licensable activities: fabricate, package/label, test, import, distribute, or wholesale of drugs. Health Canada inspects these sites to verify requirements for good manufacturing practices (GMP) are met before DEL issuance. This helps ensure that safety and quality standards are met by those selling drugs to Canadians"--Purpose, page 4.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.909078&sl=0
| Department/Agency | Canada. Health Canada, issuing body. |
|---|---|
| Title | Good manufacturing practices inspection policy for drug establishments : POL-0011. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Politique d'inspection des bonnes pratiques de fabrication pour les établissements de drogues : POL-0011. "Pub.: 210725." Issued also in HTML format. Includes bibliographical references (pages 20-22). |
| Publishing information | [Ottawa] : Health Canada = Santé Canada, April 7, 2022. ©2022 |
| Description | 1 online resource (22 pages) |
| ISBN | 9780660425481 |
| Catalogue number |
|
| Subject terms | Pharmaceutical industry -- Licenses -- Canada. Pharmaceutical industry -- Canada -- Quality control. Drugs -- Standards -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: